Basit öğe kaydını göster

dc.contributor.authorO'Byrne, James J.
dc.contributor.authorTarailo-Graovac, Maja
dc.contributor.authorGhani, Aisha
dc.contributor.authorChampion, Michael
dc.contributor.authorDeshpande, Charu
dc.contributor.authorDursun, Ali
dc.contributor.authorOzgul, Riza K.
dc.contributor.authorFreisinger, Peter
dc.contributor.authorGarber, Ian
dc.contributor.authorHaack, Tobias B.
dc.contributor.authorHorvath, Rita
dc.contributor.authorBarić, Ivo
dc.contributor.authorHusain, Ralf A.
dc.contributor.authorKluijtmans, Leo A.J.
dc.contributor.authorKotzaeridou, Urania
dc.contributor.authorMorris, Andrew A.
dc.contributor.authorRoss, Colin J.
dc.contributor.authorSantra, Saikat
dc.contributor.authorSmeitink, Jan
dc.contributor.authorTarnopolsky, Mark
dc.contributor.authorWortmann, Saskia B.
dc.contributor.authorMayr, Johannes A.
dc.contributor.authorBrunner-Krainz, Michaela
dc.contributor.authorProkisch, Holger
dc.contributor.authorWasserman, Wyeth W.
dc.contributor.authorWevers, Ron A.
dc.contributor.authorEngelke, Udo F.
dc.contributor.authorRodenburg, Richard J.
dc.contributor.authorTing, Teck Wah
dc.contributor.authorMcFarland, Robert
dc.contributor.authorTaylor, Robert W.
dc.contributor.authorSalvarinova, Ramona
dc.contributor.authorvan Karnebeek, Clara D.M.
dc.date.accessioned2019-12-10T10:51:32Z
dc.date.available2019-12-10T10:51:32Z
dc.date.issued2018
dc.identifier.issn1096-7192
dc.identifier.urihttps://doi.org/10.1016/j.ymgme.2017.11.003
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780301/
dc.identifier.urihttp://hdl.handle.net/11655/14454
dc.description.abstract• The phenotypic and genotypic spectrum of MTO1 deficiency is more variable than previously reported • Hallmark features: cardiomyopathy, lactic acidosis, developmental delay, failure to thrive, seizures, optic atrophy, ataxia • 19 pathogenic MTO1 mutations (splice-site, frameshift, missense) were identified with a geno-phenotype relation • Suspect MTO1 deficiency based on clinical features, mitochondrial markers in body fluids, low complex I III IV activity • Although ketogenic diet exerted subjective improvement in some cases, there is exists no evidence-based effective therapy
dc.relation.isversionof10.1016/j.ymgme.2017.11.003
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleThe Genotypic and Phenotypic Spectrum of Mto1 Deficiency
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalMolecular Genetics and Metabolism
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları
dc.identifier.volume123
dc.identifier.issue1
dc.identifier.startpage28
dc.identifier.endpage42
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster